MHIV.F Stock Overview
Invesque Inc. operates as a health care real estate company in North America.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Invesque Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.20 |
52 Week High | CA$0.92 |
52 Week Low | CA$0.0022 |
Beta | 1.09 |
1 Month Change | -20.00% |
3 Month Change | -11.11% |
1 Year Change | -77.01% |
3 Year Change | -93.51% |
5 Year Change | -97.06% |
Change since IPO | -98.02% |
Recent News & Updates
Recent updates
Shareholder Returns
MHIV.F | US Real Estate | US Market | |
---|---|---|---|
7D | 0% | 1.7% | 0.7% |
1Y | -77.0% | 13.4% | 23.9% |
Return vs Industry: MHIV.F underperformed the US Real Estate industry which returned 13.4% over the past year.
Return vs Market: MHIV.F underperformed the US Market which returned 23.9% over the past year.
Price Volatility
MHIV.F volatility | |
---|---|
MHIV.F Average Weekly Movement | 1,068.7% |
Real Estate Industry Average Movement | 6.1% |
Market Average Movement | 6.1% |
10% most volatile stocks in US Market | 16.6% |
10% least volatile stocks in US Market | 3.0% |
Stable Share Price: MHIV.F's share price has been volatile over the past 3 months.
Volatility Over Time: MHIV.F's weekly volatility has increased from 473% to 1069% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 1,766 | Scott White | invesque.com |
Invesque Inc. operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and transitional care properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services.
Invesque Inc. Fundamentals Summary
MHIV.F fundamental statistics | |
---|---|
Market cap | US$11.30m |
Earnings (TTM) | -US$90.11m |
Revenue (TTM) | US$195.39m |
0.1x
P/S Ratio-0.1x
P/E RatioIs MHIV.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MHIV.F income statement (TTM) | |
---|---|
Revenue | US$195.39m |
Cost of Revenue | US$131.64m |
Gross Profit | US$63.75m |
Other Expenses | US$153.86m |
Earnings | -US$90.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.60 |
Gross Margin | 32.63% |
Net Profit Margin | -46.12% |
Debt/Equity Ratio | 440.2% |
How did MHIV.F perform over the long term?
See historical performance and comparison